Aia Group LTD Hutchmed (China) LTD Put Options Transaction History
Aia Group LTD
- $4.23 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding HCM
# of Institutions
62Shares Held
6.07MCall Options Held
0Put Options Held
0-
Schroder Investment Management Group London, X02.58MShares$37.2 Million0.03% of portfolio
-
Allianz Asset Management Gmb H Munich, 2M925KShares$13.3 Million0.02% of portfolio
-
State Street Corp Boston, MA329KShares$4.74 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY289KShares$4.17 Million0.0% of portfolio
-
M&G PLC London, X0260KShares$3.75 Million0.02% of portfolio
About HUTCHMED (China) Ltd
- Ticker HCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 172,955,008
- Market Cap $2.5B
- Description
- HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...